Agios Pharm (AGIO) Financials

$33.13

$-1.00 (-2.93%)

As on 03-Sep-2026 16:00EDT

Market cap

$1,989 Mln

Revenue (TTM)

$98 Mln

P/E Ratio

--

P/B Ratio

2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	98.34	54.03	36.50	26.82	14.24	0.04
Cost of Revenue	11.88	11.52	4.17	9.50	1.70	18.78
Gross Profit	86.46	42.51	32.33	17.32	12.54	-18.78
Operating Expenses	545.49	514.64	458.07	408.81	401.58	359.64
Operating Profit (EBIT)	-459.02	-472.13	-425.74	-391.49	-389.05	-378.42
Other Income	--	--	--	--	29.39	21.91
Profit before Tax	-412.30	-413.80	717.97	-352.09	-231.80	-356.51
Provision for Tax	-1.02	-1.02	44.24	6.46	-157.25	-1,977.94
Profit after Tax (Net Income)	-411.29	-412.78	673.73	-352.09	-231.80	1,604.72
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-231.80	1,604.72

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	1,026.02	1,193.11	1,540.96	811.02	1,100.81	1,291.98
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	12.19	21.91	41.09	58.14	75.28	85.94
Current Liabilities	70.22	82.21	81.16	67.96	62.63	59.83
Total Liabilities	1,178.64	1,297.23	1,663.20	937.12	1,238.72	1,437.74

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	390.76	355.17	697.60	103.28	405.95	373.51
Current Assets	717.67	942.05	965.60	833.84	832.77	1,064.23
Total Assets	1,178.64	1,297.23	1,663.20	937.12	1,238.72	1,437.74
Total Debt*	31.17	40.21	56.99	72.00	85.66	97.09
Net Current Assets	647.45	859.85	884.44	765.88	770.14	1,004.41

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-372.98	-389.84	-296.06	-309.48	-407.32
Cash Flow from Investing Activities	--	377.18	363.44	239.58	243.26	1,248.78
Cash from Financing Activities	--	8.68	14.44	5.43	2.35	-765.77
Net Cash Inflow / Outflow	--	--	--	--	-63.87	75.69

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-7.01	-7.08	11.79	-6.30	-4.23	29.53
Cash EPS ($)	--	-6.99	11.89	-6.18	-4.07	29.70
Adjusted Book Value ($)	--	20.45	26.96	14.51	20.09	23.78
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-6.39	-6.82	-5.30	-5.65	-7.50
Free Cash Flow per Share ($)	--	-6.47	-6.85	-5.31	-5.74	-7.60

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-29.16	54.31	-34.03	-18.00	169.47
ROE (%)	-37.07	-30.20	57.29	-36.83	-19.37	189.74
ROA (%)	-30.24	-27.89	51.82	-32.36	-17.32	140.11
EBIT Margin (%)	-429.29	-765.89	1,967.15	-1,312.63	-1,627.82	-860,948.10
Net Margin (%)	-418.24	-764.01	1,845.92	-1,312.63	-531.25	7,310.97
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	140.58	0.48	0.36	0.88	342.89	-1.00
EBIT Growth (%)	-160.80	-157.63	303.92	-51.89	34.98	-8.26
Net Profit Growth (%)	-163.27	-161.27	291.35	-51.89	-114.44	590.18
EPS Growth (%)	-163.46	-1.60	2.87	-0.49	-1.14	7.25
Book Value Growth (%)	-27.04	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-3.85	2.79	-3.54	-6.64	1.11
Price / Book Value	1.99	1.33	1.22	1.53	1.40	1.38
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-2.33	-1.89	1.44	-1.56	-3.77	-2.56
Close Price ($)	37.11	27.22	32.86	22.27	28.08	32.87
High Price ($)	46.00	46.00	62.58	31.56	35.12	62.16
Low Price ($)	22.24	22.24	20.96	19.80	16.75	29.21
Market Cap ($ Cr)	1,989.27	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.03	0.04	0.09	0.08	0.08
Short term debt to equity ratio	0.02	0.02	0.01	0.02	0.01	0.01
Current Ratio	10.22	11.46	11.90	12.27	13.30	17.79
Quick Ratio	9.79	11.06	11.56	11.99	13.16	17.52
Interest Coverage	--	--	--	--	-18.12	-426.45

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	20.45	19.58	11.26	10.48	15.49	10,572.58
Asset Turnover	0.07	0.04	0.03	0.02	0.01	0.00
Receivable days	--	49.64	34.62	34.15	84.44	131,324.70
Inventory Days	--	959.50	2,047.33	529.74	2,645.28	300.42
Payable days	--	554.72	1,158.58	545.65	3,784.97	334.81
Cash Conversion Cycle	--	454.42	923.37	18.24	-1,055.25	131,290.31

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.